MH

Mark Herbert

Chief Business Officer

METiS Therapeutics

Redondo Beach, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
METiS Therapeutics
Industry
pharmaceuticals
Employees
31.0
Seniority
C suite
Annual Revenue
3200000.0
Total Funding
86000000.0
Latest Funding
Series A

Professional Summary

Mark Herbert serves as Chief Business Officer at METiS Therapeutics. METiS Therapeutics operates in the pharmaceuticals sector with approximately 31.0 employees. The company is headquartered in Redondo Beach, California. METiS Therapeutics generates annual revenue of 3200000.0. To date, METiS Therapeutics has raised 86000000.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

  • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
  • 13,743 executive contacts are available in California.
  • Our database includes 201,469 c suite-level executives.

Technologies

Microsoft Office 365 Google Cloud Hosting Varnish Wix Mobile Friendly Remote AI

Keywords

pharmaceutical manufacturing ai drug discovery artificial intelligence machine learning molecular dynamics novel therapeutics small molecules biologics advanced nucleic acids lead programs high-throughput screening lnps curative therapies target delivery systems rna therapies gene therapies predictive ai platform clinical value safety profiles high delivery efficiency partnering novel nanoparticles drug development therapeutics in vivo screening research collaboration investor relations drug discovery partnership opportunities innovation in medicine biotechnology healthcare solutions targeted therapies translational medicine personalized medicine pharmaceutical technology clinical research pipeline development therapeutic targets drug formulation nanotechnology disease treatment health technology advanced delivery systems healthcare innovation biomedical applications research & development strategic partnerships scientific discovery drug efficacy pharmaceuticals medical information technology & services

Related Executives

YM
Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions
RB
Ronan Brown Chief Operating Officer at 4G Clinical
HK
Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation
LJ
Lars Jensen CEO at A-apoteket
TL
Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Mark Herbert in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at METiS Therapeutics.

Frequently Asked Questions

How do I reach Mark Herbert directly?

Mark Herbert's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Business Officer at METiS Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Mark Herbert work for?

Mark Herbert is Chief Business Officer at METiS Therapeutics, a company in the pharmaceuticals sector with 31.0 employees. The company is based in Redondo Beach, California.

Can I pitch or sell to Mark Herbert?

As Chief Business Officer at METiS Therapeutics, Mark Herbert is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Mark Herbert directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Mark Herbert in?

Mark Herbert works in the pharmaceuticals industry as Chief Business Officer at METiS Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Mark Herbert's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Herbert's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: May 12, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans